British regulations halt world’s first magic mushroom depression trial

British regulations halt world’s first magic mushroom depression trial ‘Insane’ British regulations are hindering medical research, a former government drugs adviser said.

David Nutt, president of the British Neuroscience Association, said that British and European regulations on the use of drugs in research forced him to stop the world’s first magic mushroom depression trial.

Prof. Nutt said he was had obtained funding for clinical trial designed to explore using an extract from magic mushrooms to treat depression, regulations blocked the trial.

Speaking at a neuroscience conference in London, he said, “We live in a world of insanity in terms of regulating drugs. We have regulations which are 50 years old… they're stopping us doing the science and I think it's a disgrace actually."

He added that he wanted explore the reservoir of under-researched illegal drugs to see if they could benefit people with some severe illnesses like depression.

Previously, he carried out small experiments on volunteers and found that an ingredient in magic mushrooms, could help in alleviating severe sorts of depression in people who didn’t respond to other treatments.

After the promising results from those experiments, the British Medical Research Council awarded him a grant of 550,000 pounds to conduct a full clinical trial, but the regulations didn’t allow.

Health: 
General: